Which of these 3 FTSE 100 ‘safe stocks’ would I buy now?

These FTSE 100 shares have seen softening share prices as investor attention turned to cyclicals and Covid-19 impacted their sales.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

sdf

2020 was a good year for safe stocks or defensive shares as pessimism hung over investors’ mood. But 2021 has not been quite as benevolent as the bulls came charging back into the stock market. FTSE 100 consumer staples and healthcare stocks have sagged as a result.

But can this be a good time to start buying these stocks? Investors’ interest could return to them as cyclical stocks become pricier by comparison.

I looked at three that have released updates recently. 

#1. Unilever: signs of turnaround

The FTSE 100 consumer goods giant Unilever (LSE: ULVR) is a big gainer at the stock market today as I write, after it posted its trading update. Even though its turnover, based on generally accepted accounting principles (GAAP), is down by around 1% for the first quarter (Q1) of 2021, its underlying numbers are strong. 

Underlying sales growth is up 5.7% to €12.3bn, driven largely by volume growth. It has benefited from a weak base of 2020, which I expect will continue to drive the rest of 2021 as well. It expects growth to be in the 3% to 5% range, which is in line with its multi-year framework. 

In a year with a weak base, however, it does not sound terribly positive to me. Also, one of its key growth markets is India, which is seeing a fresh wave of coronavirus restrictions. 

I like the stock as a long-term buy, but if I had a three-year holding period in mind, I will consider it carefully. 

#2. GlaxoSmithKline: results disappoint

The FTSE 100 pharmaceuticals and healthcare biggie, GlaxoSmithKline, posted a poor set of Q1 2021 results yesterday with an 18% fall in turnover compared to Q1 2020. Net profits fell by 25% and earnings per share are down by 32%. 

The company attributes this washout performance to Covid-19-related disruptions. Considering its strong performance in the years before, I am optimistic for its future. This is further strengthened by the fact that it expects “meaningful improvements…in revenues and margins”.

It also has a strong dividend yield of around 6%. I would consider buying it from the income perspective. 

#3. Reckitt Benckiser: mixed bag

Consumer healthcare biggie Reckitt Benckiser, or Reckitt as it now prefers to be called, posted a mixed bag of a trading update yesterday. Its reported a 1.1% decline in reported revenues because of currency fluctuations. 

Its like-for-like sales, however, were up by 4.1%, driven by a huge 28.5 % increase in its hygiene business. The growth in hygiene came from brands like Lysol, Air Wick, and Finish, with geographies like the US, UK, and India reporting double-digit growth. 

But its two other segments, health and nutrition, shrank in Q1, 2021 driven by Covid-19-related restrictions. Like Unilever, another coronavirus wave in India could impact Reckitt in 2021 too. In any case, it expects like-for-like sales to slow down to 2% for the year. 

I would wait and see how its situation develops before buying Reckitt. 


Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Manika Premsingh has no position in any of the shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline and Unilever. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Investing Articles

Low P/E ratios, yields up to 9%! Are these the FTSE 250’s best value stocks?

These FTSE 250 shares offer exceptional all-round value on paper. But are they too good to be true for investors…

Read more »

Young mixed-race woman jumping for joy in a park with confetti falling around her
Investing Articles

Here’s how a 39-year-old could aim for a million by retirement, by spending £900 a month on UK shares

Our writer digs into the theory and practicalities of buying high-quality UK shares regularly to aim to retire as a…

Read more »

Businessman with tablet, waiting at the train station platform
Investing Articles

See how much a 50-year-old should invest to get a £1k monthly passive income at 65

Even at 50, there's still time to build a big enough stocks portfolio to generate a serious passive income at…

Read more »

Hand of person putting wood cube block with word VALUE on wooden table
Investing Articles

With P/E ratios below 7, are these undervalued FTSE shares bargains — or value traps?

Low valuations aren’t always the bargains they seem. Mark Hartley takes a closer look at two FTSE shares trading at…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

3 simple strategies that can help drive success in the stock market on a small budget

Christopher Ruane runs through a trio of strategic moves he reckons can help an investor as they aim to build…

Read more »

British union jack flag and Parliament house at city of Westminster in the background
Investing Articles

2 growth stocks backed by this British fund that’s soared 77.8% in just 3 years!

Our writer likes the look of this under-the-radar fund, especially with a pair of exciting growth stocks near the top…

Read more »

Shot of an young mixed-race woman using her cellphone while out cycling through the city
Investing Articles

Is there value in Baltic Classifieds — a soaring growth stock that brokers are buying?

Baltic Classifieds has surged after broker upgrades. Mark Hartley asks whether this FTSE 250 stock is really worth buying now.

Read more »

Close-up image depicting a woman in her 70s taking British bank notes from her colourful leather wallet.
Investing Articles

£20k in an ISA? Here’s how it could be used to target £423 of passive income each month

Earning money from dividends in an ISA is one way to set up passive income streams. Our writer explains how…

Read more »